Literature DB >> 6969857

Flow cytometry analysis of T cells and continuous T-cell lines from autoimmune MRL/l mice.

D E Lewis, J V Giorgi, N L Warner.   

Abstract

The study of spontaneous autoimmunity in mouse models affords an opportunity to determine the cellular basis of the immune dysregulation observed in this disease. Recently, a new mouse strain, MRL/Mp-Ipr/Ipr (MRL/l) has been developed which carries an autosomal recessive gene (lpr) that results in massive lymph node enlargement concomitant with the development of several autoantibodies. The interest in this strain lies in the possibility that the defect in T-cell regulation of the immune response is manifested at a different level from that in the NZB mouse. It has been reported that the proliferating population of lymphoid cells in the nodes of these mice are T cells, but that many of them are devoid of Lyt surface antigens. We have accordingly initiated several lines of research with these mice, including quantitative flow cytometry characterization of Lyt antigen expression of cells in the lymph nodes of the mice. In an approach to isolate and study the properties of these cells, we have also established continuous cell lines from the lymph node cells of MRL/l mice, using techniques similar to those used to establish continuous lines of antigen-activated cytotoxic T cells and helper T-cell populations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6969857     DOI: 10.1038/289298a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  26 in total

1.  Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis.

Authors:  C F Moyer; J D Strandberg; C L Reinisch
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

2.  A new T cell subset expressing B220 and CD4 in lpr mice: defects in the response to mitogens and in the production of IL-2.

Authors:  T Asano; S Tomooka; B A Serushago; K Himeno; K Nomoto
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

3.  Comparative analysis of mediastinal fat-associated lymphoid cluster development and lung cellular infiltration in murine autoimmune disease models and the corresponding normal control strains.

Authors:  Yaser Hosny Ali Elewa; Osamu Ichii; Yasuhiro Kon
Journal:  Immunology       Date:  2015-11-16       Impact factor: 7.397

4.  Overexpression of src family gene for tyrosine-kinase p59fyn in CD4-CD8- T cells of mice with a lymphoproliferative disorder.

Authors:  T Katagiri; K Urakawa; Y Yamanashi; K Semba; T Takahashi; K Toyoshima; T Yamamoto; K Kano
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  Oligoclonality of T cells in salivary glands of autoimmune MRL/lpr mice.

Authors:  K Skarstein; R Holmdahl; A C Johannessen; R Jonsson
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

6.  Aberrant lymphocyte trafficking in murine systemic lupus erythematosus.

Authors:  L Schrieber; A D Steinberg; Y J Rosenberg; E E Csehi; S A Paull; T J Santoro
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

7.  Increased Ia expression, T lymphocyte subset abnormalities and autoimmunity in murine strains bearing the lpr gene.

Authors:  M J Dauphinée; N Talal
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

8.  A pharmacologic study of the relationship between lymphocyte function and surface antigen expression.

Authors:  M L Bliven; A C Cunningham; I G Otterness
Journal:  Agents Actions       Date:  1988-08

9.  Unusual cell surface properties of the T lymphocyte population expanding in MRL/Mp-lpr/lpr mice.

Authors:  F Dumont; R G Habbersett
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

10.  Pulmonary inflammation in autoimmune MRL/Mp-lpr/lpr mice. Histopathology and bronchoalveolar lavage evaluation.

Authors:  E V Sunderrajan; W N McKenzie; T R Lieske; J L Kavanaugh; S R Braun; S E Walker
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.